omniox.comBioTechFounded: 2006Funding to Date: $87.65MM
Omniox is a provider of biotherapeutics for ischemic, hypoxic, and anemic diseases in oncology, cardiovascular and stroke diseases, diabetes, trauma, surgery, and sickle cell crises with a focused on overcoming biochemical shortcomings in prior efforts at oxygen and nitric oxide delivery.
